MedPath

Epidermal Cells Delivery and Acute Burns

Phase 3
Terminated
Conditions
Burn
Registration Number
NCT00774033
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The aim of the study is to compare results obtained with epidermal cell spray and classic skin grafting for epidermal replacement in acute burns

Detailed Description

Comparing the impact in terms of cicatrisation duration and costs between 2 treatments of deep 2nd and 3rd degree burns.

Determine if the costs of the innovating treatment RECELL®, a priori more expensive, are counterbalanced by a shorter cicatrisation duration and an improved evolution versus a conventional strategy.

Give an information about efficiency improvement of RECELL® with additional costs

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Thermal burns requiring surgical debridement
  • Area involved < 1260cm²
Exclusion Criteria
  • local or systemic infection
  • conditions that would interfere with wound healing (diabetes, hypertension, inflammatory diseases treated by corticoids)
  • hypersensitivity to trypsin

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
80% epithelialisation (recipient + owner sites) at one week. Percent epithelialisation at 1, 2 and 6 weeks.at 1, 2 and 6 weeks
Secondary Outcome Measures
NameTimeMethod
Medical costs at complete epithelialisationAt 6, 12 and 18 months
Post-operative painAt 6 weeks
Medical assessment of scar qualityat 6 weeks and 6, 12, 18 months
Patient self assessment of scarAt 6, 12 and 18 months

Trial Locations

Locations (1)

Hopital Trousseau

🇫🇷

Paris, France

Hopital Trousseau
🇫🇷Paris, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.